Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes.

Anna E M BastiaansenAdriaan H C de JongsteMarienke A A M de BruijnYvette S CrijnenMarco W J SchreursMarcel M VerbeekDaphne W DumoulinWalter TaalMaarten J TitulaerPeter A E Sillevis Smitt

Published in: Neuro-oncology advances (2021)

https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-000675-13/NL.

Keyphrases

multiple sclerosis
clinical trial
study protocol
open label
phase iii
phase ii
subarachnoid hemorrhage
brain injury
blood brain barrier
replacement therapy
cerebral ischemia